Ekonomi Netral
Ekosistem Kesehatan Menguat, Penjualan Medela Potentia Tumbuh 10,1 Persen
PT Medela Potentia Tbk (MDLA) mencatatkan penjualan Rp8,2 triliun pada semester I 2026, tumbuh 10,1 persen year-on-year, dengan laba bersih naik 12,6 persen menjadi Rp226 miliar. Pertumbuhan ditopang oleh ekspansi distribusi melalui penambahan lima prinsipal baru, penguatan produk sendiri seperti Stardec, optimalisasi kanal digital GPOS B2B, serta pembangunan infrastruktur gudang. Perseroan juga menjalankan agenda keberlanjutan melalui pemasangan panel surya, elektrifikasi armada, program sosial Argon Peduli, dan penguatan tata kelola distribusi obat.
Poin-Poin Utama
- PT Medela Potentia Tbk (MDLA) reported semester I 2026 sales of Rp8.2 trillion, up 10.1 percent year-on-year.
- Net profit rose 12.6 percent to Rp226 billion in semester I 2026.
- Gross profit increased 6.8 percent to Rp762 billion.
- EBITDA grew 11.2 percent to Rp325 billion.
- Subsidiary PT Anugrah Argon Medica (AAM) added five new principals: one ethical, three consumer health, and one medical device.
- Stardec medical device sales grew 34 percent, supported by launches of Stardec DecaCare 5 Liter and Stardec DecaFoam.
- Stardec products were exported to Cambodia and Timor-Leste in 2025, with further exports planned for 2026.
- AAM Medan warehouse construction reached 95 percent completion, targeted to operate in Q4 2026.
- National Distribution Center (NDC) 2 planned for 2027 on a 2.7-hectare site at Kawasan Industri Jababeka 2, focused on cold storage.
- GPOS B2B digital platform recorded 20 percent sales growth and 15 percent coverage increase.
- GPOS B2B partners with 18 principals covering 40 product brands.
- AI Forecast implementation reduced out-of-stock rate to below 2 percent.
- Solar panels with 93.75 kWp DC capacity installed at AAM Tangerang.
- Fleet electrification includes 107 electric vehicles across 15 branches and 13 cities.
- Argon Peduli program reached 8,505 people across 27 cities, 18 provinces, and six islands, involving 56 communities.
Ingin membaca liputan lengkap di portal penerbit?
Buka Sumber di RepublikaHak cipta dan publikasi utuh dimiliki oleh Republika.